Funding
ALSPAC
The Avon Longitudinal Study of Parents and Children (ALSPAC) receives core funding from the University of Bristol, UK Medical Research Council and Wellcome (217065/Z/19/Z). A comprehensive list of grants funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf).
Generation R
The general design of the Generation R Study is made possible by financial support from the Erasmus MC, University Medical Centre, Rotterdam, Erasmus University Rotterdam, Netherlands Organization for Health Research and Development (ZonMw), Netherlands Organisation for Scientific Research (NWO), Ministry of Health, Welfare and Sport and Ministry of Youth and Families. This project received funding from the European Union's Horizon 2020 research and innovation programme (LIFECYCLE, grant agreement No 733206, 2016; EUCAN-Connect grant agreement No 824989; ATHLETE, grant agreement No 874583).
DNBC
The Danish National Birth Cohort (DNBC) was established with a significant grant from the Danish National Research Foundation. Additional support was obtained from the Danish Regional Committees, the Pharmacy Foundation, the Egmont Foundation, the March of Dimes Birth Defects Foundation, the Health Foundation and other minor grants. The DNBC Biobank has been supported by the Novo Nordisk Foundation and the Lundbeck Foundation. Follow-up of mothers and children have been supported by the Danish Medical Research Council (SSVF 0646, 271-08-0839/06-066023, O602-01042B, 0602-02738B), the Lundbeck Foundation (195/04, R100-A9193), The Innovation Fund Denmark 0603-00294B (09-067124), the Nordea Foundation (02-2013-2014), Aarhus Ideas (AU R9-A959-13-S804), University of Copenhagen Strategic Grant (IFSV 2012), and the Danish Council for Independent Research (DFF – 4183-00594 and DFF - 4183-00152).
INMA
the INfancia y Medio Ambiente Project (INMA) was funded by grants from the Instituto de Salud Carlos III (Red INMA G03/176) and the Generalitat de Catalunya-CIRIT (1999SGR 00241). INMA-Valencia was funded by Grants from UE (FP7-ENV-2011 cod 282957 and HEALTH.2010.2.4.5-1), Spain: ISCIII (G03/176; FIS-FEDER: PI09/02647, PI11/01007, PI11/02591, PI11/02038, PI13/1944, PI13/2032, PI14/00891, PI14/01687, and PI16/1288; Miguel Servet-FEDER CP11/00178, CP15/00025, and CPII16/00051), and Generalitat Valenciana: FISABIO (UGP 15-230, UGP-15-244,and UGP-15-249). INMA-Gipuzkoa was funded by grants from the Instituto de Salud Carlos III (FISFIS PI06/0867, FISPS09/0009) 0867,Red INMA G03/176) and the Departamento de Salud del Gobierno Vasco (2005111093 and 2009111069) and the Provincial Government of Guipúzcoa (DFG06/004 and FG08/001). INM-Menorca was funded by grants from the Instituto de Salud Carlos III (Red INMA G03/176). This study was supported by funding from the European Community’s Seventh Framework Programme (FP7/2007-206) under grant agreement no 308333—the HELIX project.
EDEN
The Étude des Déterminants pré Et postnatals du Développement de la santé de l'enfant (EDEN) study was supported by Foundation for medical research (FRM), National Agency for Research (ANR), National Institute for Research in Public health (IRESP: TGIR cohorte santé 2008 program), French Ministry of Health (DGS), French Ministry of Research, INSERM Bone and Joint Diseases National Research (PRO-A) and Human Nutrition National Research Programs, Paris-Sud University, Nestlé, French National Institute for Population Health Surveillance (InVS), French National Institute for Health Education (INPES), the European Union FP7 programmes (FP7/2007-2013, HELIX, ESCAPE, ENRIECO, Medall projects), Diabetes National Research Program (through a collaboration with the French Association of Diabetic Patients (AFD)), French Agency for Environmental Health Safety (now ANSES), Mutuelle Générale de l’Education Nationale a complementary health insurance (MGEN), French national agency for food security, French speaking association for the study of diabetes and metabolism (ALFEDIAM).
The study received approval from the ethics committee (CCPPRB) of Kremlin Bicêtre on 12 December 2002 and from CNIL (Commission Nationale Informatique et Liberté), the French data privacy institution. Women gave written informed consent for themselves and their child. Fathers gave written informed consent for themselves.
ELFE
The Étude Longitudinale Française depuis l'Enfance (ELFE) cohort received funding from the National Research Agency Investment for the Future program [ANR-11-EQPX-0038]; French National Institute for Research in Public Health (IRESP TGIR 2009-2001 program); Ministry of Higher Education and Research; Ministry of Environment; Ministry of Health; French Agency for Public Health; Ministry of Culture; and National Family Allowance Fund.
Competing interests
The authors have no conflicts of interest to declare that are relevant to the content of this article.
Author contributions
KMB, DA and MM conceptualized and designed the present study. interpretation of the results. KMB, DA, and TC planned and performed the statistical and data analysis. KMB drafted the article. DA, TM, AE, HEM, PWJ, MW, AMNA, KSL, LGS, RSB, FBZ, JJ, MV, BH, MAC, ARG, and MM provided insights on the interpretation of the data and additional analyses to perform. All authors read and revised this manuscript critically for important intellectual content and finally approved this version of the manuscript for submission.
Ethics approval
ALSPAC
Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees. Informed consent for the use of data collected via questionnaires and clinics was obtained from participants following the recommendations of the ALSPAC Ethics and Law Committee at the time Pregnant women resident in Avon, UK with expected dates of delivery 1st April 1991 to 31st December 1992 were invited to take part in the study.
Generation R
The general design, all research aims and the specific measurements in the Generation R Study have been approved by the Medical Ethical Committee of Erasmus MC, University Medical Center Rotterdam. Participants need to give written informed consent for each phase of the study (fetal, preschool, childhood and adolescence period).
DNBC
The Danish National Birth Cohort (DNBC) is a nationwide longitudinal cohort that enrolled pregnant women through their general practitioners during early gestation (weeks 6 to 12) (Olsen et al., 2001). Written informed consent was obtained from all participants at recruitment, and again during followed up.
INMA
The study has been approved by Ethical Committee of each participating centre and written consent was obtained from participating parents. Data for this study comes from INMA-Asturias, INMA-Gipuzkoa, INMA-Sabadell and INMA-Valencia subcohorts.
EDEN
The study received approval from the ethics committee (CCPPRB) of Kremlin Bicêtre on 12 December 2002 and from CNIL (Commission Nationale Informatique et Liberté), the French data privacy institution. All subjects gave their informed consent for inclusion before they participated in the study. Consent for the child was obtained from both parents after the child's birth
ELFE
Ethical approvals for data collection in maternity units and for each data collection wave during follow-up were obtained from the national advisory committee on information processing in health research (CCTIRS: Comité Consultatif sur le Traitement de l’Information en matière de Recherche dans le domaine de la Santé), the national data protection authority (CNIL: Comission Nationale Informatique et Liberté) and, in case of invasive data collection such as biological sampling, the committee for protection of persons engaged in research (CPP: Comité de Protection des Personnes). The ELFE study was also approved by the national committee for statistical information (CNIS: Conseil National de l’Information Statistique). Informed consent was signed by the parents or the mother alone, with the father being informed of his right to deny consent for participation.
Consent to participate
ALSPAC
Participants who returned completed questionnaires (either by post or by email) provided written consent to participate.
Generation R
Participants provided written informed consent for each phase of the study (fetal, preschool, childhood and adolescence period).
DNBC
Written informed consent was obtained from all participants at recruitment, and again during followed up.
INMA
Written consent was provided by all participating parents at the beginning of the study.
EDEN
Consent for the child was obtained from both parents after the child's birth
ELFE
Informed consent was signed by the parents or the mother alone, with the father being informed of his right to deny consent for participation.
Availability of Data and Materials
The datasets generated and analyzed during the current study are not publicly available due to data regulations and for ethical reasons, considering that this information might compromise research participants’ consent because our participants only gave their consent for the use of their data by the original team of investigators. However, all the code for the data management and analysis are open sourced and publicly available: https://github.com/katybarry/nonparental-care-attendance-and-childrens-behaviors.git